Disparities in cervical cancer mortality rates as determined by the longitudinal hyperbolastic mixed-effects type II model

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Tabatabai, Mohammad A ^a   Kengwoung Keumo, Jean Jacques ^b   Eby, Wayne M ^c   Bae, Sejong ^d   Guemmegne, Juliette T ^e   Manne, Upender ^f   Fouad, Mona ^d   Partridge, Edward E ^g   Singh, Karan P ^d  

^a MEHARRY MEDICAL COLLEGE   (United States)

^b CAMERON UNIVERSITY   (United States)

^c NEW JERSEY CITY UNIVERSITY   (United States)

^d University of Alabama at Birmingham   (United States)

^e UNIVERSITY OF NEW MEXICO   (United States)

^f University of Alabama at Birmingham   (United States)

^g UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICAN AMERICAN; ARTICLE; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CAUCASIAN; CONTROLLED STUDY; FEMALE; HUMAN; RACE DIFFERENCE; RISK FACTOR; SOCIAL STATUS; STATISTICAL MODEL; SURVIVAL RATE; UNITED STATES; UTERINE CERVIX CANCER; ALGORITHM; CANCER REGISTRY; ETHNOLOGY; HISTORY; MORTALITY; TEXAS; UTERINE CERVICAL NEOPLASMS;

AFRICAN AMERICANS; ALGORITHMS; APPALACHIAN REGION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MODELS, STATISTICAL; MORTALITY; SEER PROGRAM; SOUTHEASTERN UNITED STATES; TEXAS; UTERINE CERVICAL NEOPLASMS;

EID: 84907222543     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107242     Document Type: Article

References (54)

1. Fenelon A (2013) An examination of black/white differences in rate of age-related mortality increase. Demogr Res 29:41-72.
2. Pong-Wong R, Hadjipavlou G (2010) A two-step approach combining the Gompertz growth model with genomic selection for longitudinal data. [Abstract] BMC Proc 4:S4.
3. Novák L, Kukla L, Čuta M (2008) Child and adolescent longitudinal growth data evaluation using logistic curve fitting with the use of dynamic phenotype method. Scripta Medica (BRBNO) 81:31-46.
4. Aggrey SE (2009) Logistic nonlinear mixed effects models for estimating growth parameters. Poult Sci 88:276-280.
5. Li Y, Jiang L (2013) Fitting logistic growth curve with nonlinear mixed-effects models. Adv J Food Sci Technol 5:392-397.
6. Tabatabai M, Williams DK, Bursac Z (2005) Hyperbolastic growth models: Theory and application. Theor Biol Med Model 2:14.
7. Eby W, Tabatabai M, Bursac Z (2010) Hyperbolastic modeling of tumor growth with a combined treatment of iodoacetate and dimethylsulfoxide. BMC Cancer 10:509.
8. Tabatabai M, Bursac Z, Eby W, Singh K (2011) Mathematical modeling of stem cell proliferation. Med Biol Eng Comp 49:253-262.
9. Tabatabai M, Eby W, Singh KP (2011) Hyperbolastic modeling of wound healing. Math Comput Model 53:755-768.
10. Tabatabai M, Eby W, Bae S, Singh KP (2013) A flexible multivariable model for phytoplankton growth. Math Biosci Engineer 10:913-923.
11. Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, et al (eds) SEER Cancer Statistics Review 1975-2010. National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975-2010/, based on November 2012 SEER data submission, posted to the SEER web site, April 2013.
12. Downs LS, Smith JS, Scarinci I, Flowers L, Parham G (2008) The disparity of cervical cancer in diverse populations. Gynecol Oncol 109:S22-S30.
13. Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, et al (2007) Prevalence of HPV infection among females in the US. JAMA 297:813-819.
14. Cherath L, Alic M. Gale Encyclopedia of Cancer: Cervical Cancer 2002. http://www.encyclopedia.com/topic/Cervical-cancer.aspx.
15. Garner E (2003) Cervical cancer: Disparities in screening, treatment, and survival. Cancer Epidemiol Biomarkers Prev 12:242s-247s.
16. Vesco KK, Whitlock EP, Eder M, Burda BU, Senger CA, et al (2011) Risk factors and other epidemiologic considerations for cervical cancer screening: A narrative review for the U.S. Preventive Services Task Force. Ann Intern Med 155:698-706.
17. McCredie MR, Sharples KJ, Paul C, Baranyai J, Medley G, et al (2008) Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol, 9:425-434.
18. International Agency for Research on Cancer, Monographs Vol 90. Human Papillomaviruses, 4. Molecular Mechanisms of HPV-Induced carcinogenesis, 2007, 432-465.
19. Dalstein V, Riethmuller D, Prétet JL, Le Bail Carval K, Sautière JL, et al (2003) Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int J Cancer 106:396-403.
20. Castellsagué X,Muñoz N. (2003) Chapter 3: Cofactors in human papillomavirus carcinogenesis - role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 31:20-28.
21. Dahlström LA, Andersson K, Luostarinen T, Thoresen S, Ögmundsdottir H, et al (2011) Prospective seroepidemiologic study of human papillomavirus and other risk factors in cervical cancer. Cancer Epidemiol Biomarkers Prev, 20:2541-2550.
22. Chattopadhyay K (2011) A comprehensive review on host genetic susceptibility to human papillomavirus infection and progression to cervical cancer. Ind J Human Genetics 17:132-144.
23. Ragasukha PN, Thulaseedharan JV, Wesley R, Jayaprakash PG, Lalitha P, et al (2012) A case-control nutrigenomic study of the synergistic activity of folate and vitamin B12 in cervical cancer progression. Nutr Cancer 64:550-558.
24. Bosch FX, de Sanjosé S (2007) The epidemiology of human papillomavirus and cervical cancer. Dis Markers 23:213-227.
25. Brooks SE, Chen TT, Ghosh A, Mullins CD, Gardner JF, et al (2000) Cervical cancer outcomes analysis: impact of age, race and comorbid illness on hospitalizations for invasive carcinoma of the cervical cancer. Gynecol Oncol 79:107-115.
26. Breen N, Wagener DK, Brown ML, Davis WW, Ballard-Barbash R (2001) Progress in cancer screening for the 1987, 1992, 1998 National Health Interview surveys. J Natl Cancer Inst 93:1704-1713.
27. Brookfield KF, Cheung MC, Lucci J, Fleming LE, Koniaris LG (2009) Disparities in survival among women with invasive cervical cancer. Cancer 115:166-178.
28. Morgan MA, Behbakht K, Benjamin I, Berlin M, King SA, et al (1996) Racial differences in survival from gynecologic cancer. Obstet Gynecol 88:914-918.
29. Farley JH, Hines JF, Taylor RR, Carlson JW, Parker MF, et al (2001) Equal care ensures equal survival for African-American women with cervical carcinoma. Cancer 91:869-873.
30. Grigsby PW, Hall-Daniels L, Baker S, Perez CA (2000) Comparison of clinical outcome in black and white women treated with radiotherapy for cervical carcinoma. Gynecol Oncol 79:357-361.
31. Mundt AM, Connell PP, Campbell T, Hwang JH, Rotmensch J, et al (1998) Race and clinical outcome in patients with carcinoma of the uterine cervical cancer treated with radiation therapy. Gynecol Oncol 71:151-158.
32. Shavers VL, Brown ML (2002) Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst 94:334-357.
33. Bazargan M, Bazargan SH, Farooq M, Baker RS (2004) Correlates of cervical cancer screening among underserved Hispanic and African-American women. Prev Med 39:465-473.
34. Adams EK, Breen N, Joski PJ (2007) Impact of the national breast and cervical cancer early detection program on mammography and pap test utilization among white, Hispanic, and African American women: 1996-2000. Cancer 109:348-358.
35. Hicks ML, Yap OW, Matthews R, Parham G (2006) Disparities in cervical cancer screening, treatment and outcomes. Ethn Dis 16:63-6.
36. Howell EA, Chen YT, Concato J (1999) Differences in cervical cancer mortality among black and white women. Obstet Gynecol 94:509-515.
37. Merrill RM, Merrill AV, Mayer LS (2000) Factors associated with no surgery or radiation therapy for invasive cervical cancer in black and white women. Ethn Dis 10:248-56.
38. Matthews AK, Li CC, Ross N, Ram J, Ramsey R, et al (2013) Breast and cervical cancer screening behaviors of African American sexual minority women. J Gen Pract 1:107.
39. Kiefe CI, Funkhouser E, Fouad MN, May DS (1998) Chronic disease as a barrier to breast and cervical cancer screening. J Gen Intern Med 13:357-365.
40. Parikh S, Brennan P, Boffetta P (2003) Meta-analysis of social inequality and the risk of cervical cancer. Intl J Cancer 105:687-691.
41. Singh GK, Miller BA, Hankey BF, Edwards BK (2004) Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975-2000. Cancer 101:1051-1057.
42. Siegel R, Ward E, Brawley O, Jemal A (2011) Cancer statistics 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. Ca Cancer J Clin 61:212-236.
43. Tehranifar P, Neugut AI, Phelan JC, Link BG, Liao Y, et al (2009) Medical advances and racial/ethnic disparities in cancer survival. Cancer Epidemiol Biomarkers Prev 18:2701-2708.
44. Ward E (2004) Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin 54:78-93.
45. Braveman PA, Cubbin C, Egerter S, Williams DR, Pamuk E (2010) Socioeconomic disparities in health in the United States: What the patterns tell us. Am J Public Health 100:S186-S196.
46. Krieger N, Rowley DL, Herman AA, Avery B, Phillips MT (1993) Racism, sexism, and social class: implications for studies of health, disease, and well-being. Am J Prev Med 9:82-122.
47. Lantz PM, Lynch JW, House JS, Lepkowski JM, Mero RP, et al (2001) Socioeconomic disparities in health change in a longitudinal study of US adults: the role of health-risk behaviors. Social Sci Med 53:29-40.
48. Peto J, Gilham C, Fletcher O, Matthews FE (2004) The cervical cancer epidemic that screening has prevented in the UK. Lancet 364:249-256.
49. Shanta V, Krishnamurthi S, Gajalakshmi CK, Swaminathan R, Ravichandran K (2000) Epidemiology of cancer of the cervical cancer: global and national perspective. J Indian Med Assoc 98:49-52.
50. de Sanjose S, Bosch FX, Munoz N, Shah K (1997) Social differences in sexual behavior and cervical cancer. IARC Sci Publ 138:309-317.
51. Bray F, Ren JS, Masuyer E, Ferlay J (2013) Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer 132:1133-1145.
52. Singh GK, Azuine RE, Siahpush M (2012) Global inequalities in cervical cancer incidence and mortality are linked to deprivation, low socioeconomic status, and human development. Int J MCH AIDS 1:17-30.
53. Schiffman MA, Wacholder S (2012) Success of HPV vaccination is now a matter of coverage. Lancet Oncol 13:10-12.
54. National Center for Health Statistics Health, United States, 2009. (http://www.cdc.gov/nchs/data/hus/hus09.pdf).